[Valencia, Calif.] – MannKind Corp. reported with deep sadness Friday the passing of Alfred E. Mann, age 90, the company’s Chairman Emeritus.
Mr. Mann was the Chairman of the Board of MannKind from 2001 until February 2016 and, from November 2003 until January 2015, was its Chief Executive Officer. Mr. Mann founded and largely funded 14 companies in his career. Nine of these companies were acquired at an overall total of almost $8 billion, and three companies became publicly traded, MannKind being one of them.
For nearly six decades, Alfred Mann was a revolutionary voice and thinker in aerospace, medical technology and biopharmaceuticals, and has led development of many products to fill unmet and poorly met medical needs. Our thoughts and condolences go out to Al’s wife, Claude, his children, and loved ones.
“Al has been a wonderful inspiration, not only to me, but to all the employees of MannKind. His kindness, generosity, and business acumen have influenced all of us with whom he has done business and charitable work over the years. He will be terribly missed by many, including the countless patients around the world with diabetes and other serious illnesses, whose lives he improved. I am thankful to have had a close relationship with Al, and will reflect on his counsel and guidance in the years to come. Our resolve is now stronger than ever to continue Al’s legacy of medical innovation, as a tribute to this remarkable man, who did so much to help mankind,” said Matthew Pfeffer, Chief Executive Officer of MannKind Corporation.
“Al’s contribution to the diabetes field is unparalleled, and he truly represents an iconic influence in the philanthropic and business arena for our generation. I’m honored to have worked for so many years with Al, and am proud to have called him my friend,” said Kent Kresa, Chairman of the Board of MannKind Corporation. No changes are anticipated in the company’s day-to-day business activities. The company’s loan agreement with The Mann Group is unaffected by the passing of Mr. Mann.
About MannKind Corp.
MannKind Corp. focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes.
In an unprecedented decision spurred by the state’s extreme drought conditions, the California Department of Water Resources announced a 0% initial allocation from the State Water Project for the upcoming year.
California State University, Northridge will launch programs in fall 2022 that will expedite the process for getting a credential for those who are interested in teaching history and social science in middle or high school.
The Santa Clarita Valley Historical Society is seeking donations to replace the original brass, 6-chime train whistle, which was stolen years ago from the Historical Society's vintage 1900 Southern Pacific locomotive.
The Santa Clarita City Council will take a major step toward enhancing one of the city of Santa Clarita’s landmark amenities by holding a groundbreaking ceremony for the Central Park Buildout project on Monday, Dec. 6.
The Board of Trustees of the Santa Clarita Community College District is undergoing the redistricting process, and community members will have the opportunity to comment on revised trustee area boundaries at two upcoming public hearings.